IDENTIFICATION OF TARGETS FOR TCR-IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA USING A CLINICALLY RELEVANT PLATFORM

被引：0
|
作者：
Maravelia, P. [1 ]
Potti, A. Perez [1 ]
Silva, D. Nascimento [1 ]
Healy, K. [1 ]
Sekine, T. [1 ]
Chrobok, M. [1 ]
Jorns, C. [1 ]
Sallberg, M. [1 ]
Buggert, M. [1 ]
Pasetto, A. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
CYTOTHERAPY | 2021年 / 23卷 / 05期
关键词：
immunotherapy; hepatocellular carcinoma; T cell receptor;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
409
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [21] Identification and validation a novel kinase-related gene signature for predicting prognosis and responsiveness to immunotherapy in hepatocellular carcinoma
    Yaju Qiu
    Xitian Wu
    Yang Luo
    Lianqiang Shen
    Anyang Guo
    Jing Jiang
    Lijuan Zhu
    Yuhua Zhang
    Fang Han
    Enyan Yu
    Clinical and Experimental Medicine, 25 (1)
  • [22] Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies
    Hoseini, Sayed Shahabuddin
    Cheung, Nai-Kong V.
    CANCER LETTERS, 2017, 399 : 44 - 52
  • [23] Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
    Genhao Zhang
    Xianping Lv
    Qiankun Yang
    Hongchun Liu
    BMC Cancer, 22
  • [24] Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
    Yang, Shiyan
    Cheng, Yajun
    Wang, Xiaolong
    Wei, Ping
    Wang, Hui
    Tan, Shanzhong
    FRONTIERS IN GENETICS, 2021, 12
  • [25] Identification of VRK1 as a Novel Potential Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
    He, Xiaoyan
    Zai, Guozhen
    Zhou, Lidan
    Chen, Shengyang
    Wang, Guizhi
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1671 - 1683
  • [26] Identification of Cuproptosis-Related Patterns Predict Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
    Guo, Kai
    Wang, Tianbing
    Yin, Jimin
    Yang, Shoushan
    Cui, Haodong
    Cao, Zichuan
    Zhao, Qiang
    Xie, Gongbo
    Lu, Jian
    Gu, Guosheng
    Wu, Wenyong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (23)
  • [27] Identification of metabolism terms significantly affecting hepatocellular carcinoma immune microenvironment and immunotherapy response
    Tan, Xijuan
    Chen, Sizong
    Luo, Qiyi
    You, Shenglin
    Yuan, Hankun
    Wang, Jianchu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (01)
  • [28] Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
    Zhang, Genhao
    Lv, Xianping
    Yang, Qiankun
    Liu, Hongchun
    BMC CANCER, 2022, 22 (01)
  • [29] Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization
    Zhu, Weixiong
    Fan, Chuanlei
    Liu, Bo
    Qin, Jianqi
    Fan, Aodong
    Yang, Zengxi
    Zhang, Hui
    Zhou, Wence
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (01) : 282 - 293
  • [30] Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis
    Hossen, Md. Alim
    Reza, Md. Selim
    Harun-Or-Roshid, Md.
    Islam, Md. Ariful
    Siddika, Mst. Ayesha
    Mollah, Md. Nurul Haque
    CURRENT CANCER DRUG TARGETS, 2023, 23 (07) : 547 - 563
12345